Dog DNA test results and pet insurance: what nine policy forms count, and what they leave out

What a DNA report records

A DNA report names a genotype: the variants a dog carries at the sites the lab tested. A sign, a diagnosis and a treatment are another kind of record, because they describe a body that has been looked at. The Orthopedic Foundation for Animals (OFA) draws the line in its FAQ: DNA tests for specific diseases "remain the 'gold standard' in determining an animal's genotype, but in the absence of available DNA tests, phenotypic evaluations are the best alternative." Pre-existing clauses are written about the second kind of record, which is why a genotype with no clinical history behind it sits awkwardly in the definitions.

The result vocabulary is also less uniform than owners expect. OFA's numbering guide shows a DNA registry number such as NF-CY500/4F-PI, built from a breed code, a disease code, a serial number, the dog's age in months when tested (4 in the example) and an identification suffix, and its legend includes "BP = By Parentage" and "CAR = Carrier." So a registered result is dated by the dog's age. The same OFA page lists its DNA tests, run through the University of Missouri Canine Genetics Lab at $65 per test with registration included, and says the cheek-swab collection "is non-invasive and no veterinary appointment is necessary" (page metadata modified March 9, 2026). A result can therefore exist without any clinic ever having touched it, which matters later when the forms ask for records.

The word carrier does not carry one meaning across disorders. Majchrakova and colleagues (PLOS ONE, published February 27, 2023) report 2,595 European Australian Shepherds tested between 2012 and 2022 for six variants, with the number tested varying by disorder as the table shows. For the hereditary cataract variant in the HSF4 gene, 23.28 percent of the dogs were carriers and the other 76.72 percent "homozygous healthy." The authors nonetheless describe the breed's cataract as an autosomal dominant form with incomplete penetrance, and they say use of heterozygotes in breeding "should be carefully considered." In a dominant disorder with incomplete penetrance, one copy can cause disease without always doing so, so "carrier" on that report is not the reassurance it would be for a recessive disorder. For degenerative myelopathy the same paper counts 22.16 percent heterozygotes and 0.69 percent homozygous for the mutant allele in its European sample.

The samples came from privately owned dogs submitted by owners or veterinarians to one laboratory; the paper says health status, medical records and other documentation of the tested dogs were unavailable and that the Hardy-Weinberg principle does not apply, so these are frequencies among dogs that were tested, not among Australian Shepherds generally. A dog is not tested for every disorder, so the counts differ by row.

Timing is the other half. Merck Veterinary Manual's owner-edition table of inherited cataracts in dogs (page last updated April 2026) gives the age of onset for Australian Shepherds as 2 to 4 years. A puppy swabbed at eight weeks and carrying that variant is, on that table, years away from the age at which signs appear. In between sit the policy start, the waiting periods, several renewals and one pre-existing clause that has nothing recorded to attach to. The Australian Shepherd page covers the breed's risk profile; the cataract surgery guide reads the same forms against eye paperwork.

Where nine forms start counting

Each form decides what makes a condition pre-existing by naming an event. Reading the definitions for the event, rather than for their general sense, gives four families. Three forms use the trio of veterinary advice, treatment and signs. Two (AKC and PetPartners) count what "existed," found or not. Two (Spot and Figo) wait for a sign or a chronic condition someone observed. Two (Trupanion and VS-21) are phrased so that nobody needs to have noticed anything. The pre-existing conditions guide walks through the general mechanics; the table isolates the words that a DNA report would have to satisfy.

Quoted from each insurer's posted document; the policy actually issued varies by state, edition and date. Trupanion (2011), PetPartners (2014), Pets Best (2015), VS-G-3-CA (2015) and VS-21 (2017) are older forms, and VS-21 and VS-G-3-CA are dated sample forms from an older Nationwide program.

Five of the nine need a sign or a veterinary contact before a condition counts: Spot, Figo, MetLife, VS-G-3-CA and Pets Best. The other four need no one to have noticed anything. AKC and PetPartners count a condition that "existed," Trupanion counts "evidence" of potential manifestation, and VS-21 counts a condition that "began or was contracted" whether or not it was "discovered." That split of five and four is the first answer to the search question. Whether a genotype can sit inside a pre-existing condition depends on which side of it the form falls, not on the lab or the result.

The same table also shows what none of the nine contain: a slot for a genotype. No form defines a result, a variant, a predisposition or a risk status, so every reading below is the form's event applied to a record the drafters never described. The NAIC Pet Insurance Model Act supplies the backdrop for the three forms that use the advice, treatment and sign trio. Its Section 3F defines a preexisting condition as one for which a veterinarian provided medical advice, the pet received previous treatment, or, "based on information from verifiable sources, the pet had signs or symptoms directly related to the condition for which a claim is being made," and its Section 5A puts the burden of proving the exclusion on the insurer. These are model provisions in the Summer 2022 compilation, and what a state enacted can differ.

Clear, carrier and at-risk, form by form

Three kinds of report need separating. A clear report finds no copy of the tested variant. A carrier report finds one copy of a variant that is recessive in the tested disorder. An at-risk or affected report finds the genotype the lab flags as raising risk: two copies of a recessive variant, or one copy of a dominant one. Each reading in the table is of the words only, for a dog with no sign, advice, treatment or diagnosis before the policy start, and none says how any insurer would decide a claim.

Readings of quoted wording; the posted forms are samples and filed forms, and the policy issued may differ.

No row turns a clear or recessive-carrier report into a pre-existing condition on the words. For an at-risk or affected report, five forms have nothing to attach to unless a veterinarian responds to it, two (AKC and PetPartners) hinge on whether a variant is an illness that "existed," and two (Trupanion and VS-21) are open on their own text. Those last two are worth reading in full, because the vendors' blanket statements do not engage their wording.

Trupanion 2011 names testing in the clause

Trupanion's TRU-00001 (08/11) is the one form among the nine whose general pre-existing exclusion names testing and screening as a way a condition becomes pre-existing. Exclusion 5.c(1) removes an illness "resulting from any condition for which evidence and/or symptoms of their potential manifestation already exist at, or during the 18 months prior to, the policy enrollment date." Exclusion 5.c(4) removes "Abnormalities that are present at, or during the 18 months prior to, the policy enrollment date. This includes conditions that are detectable by a routine physical exam by your veterinarian or those that have been noted from diagnostic testing, screening or radiographs."

Two features of the form make a genotype harder to dismiss here than under a sign-based wording. The first is the pairing of "evidence" with "potential manifestation." The form separately defines "Clinical symptoms" as "Any manifested anomaly in, or deviation from the regular healthy state or function of a pet," so the drafters had a word for a manifested problem and chose a broader phrase for the pre-existing exclusion. The second is the form's own definition of diagnostic tests: "Tests used to determine the overall health of your pet. Diagnostic tests can be used as a way to detect certain abnormalities, validate the current health of your pet or help to evaluate an older pet more thoroughly before problems surface." That sentence describes testing of a healthy dog, before signs, in the same vocabulary that 5.c(4) uses for what makes an abnormality pre-existing. A vendor's statement that genetic screening is "prognostic" rather than "diagnostic" does not engage that sentence, because the form does not use the word prognostic.

The counter-reading is just as grounded in the text. Every item next to "screening" in 5.c(4), the routine physical exam by "your veterinarian" and "radiographs," is a veterinary activity, and the form defines the benefit "Diagnostic tests" as part of "veterinary treatment" in section 2. A swab ordered by an owner from a consumer lab and never shown to a clinic is arguably none of those, and "abnormality" in a form that otherwise talks about symptoms and conditions could be read as a physical finding. Under that reading the report becomes relevant when a veterinarian files it in the chart or acts on it. Both readings are available, and the form does not choose between them. The 18-month window does not help either way: a genotype is present from birth, and "present at" the enrollment date is already enough in 5.c(4).

One more fact separates Trupanion's form from seven of the other eight. A search of the saved text finds no hereditary, inherited, congenital or genetic wording anywhere in it. For this 2011 form the DNA question is therefore entirely a pre-existing question, with no second clause behind it. The form is dated August 2011 and does not show the insurer's current terms. A later Trupanion edition posted on the same server, TRU 00001 (v07.201405), words the pre-existing test as signs or evidence of potential manifestation within 18 months, or illnesses that would have been observable or reasonably known to be present, and no longer contains the words "abnormalities" or "screening".

Hereditary wording in the Nationwide forms

Nationwide's VS-21 (02-17) is built differently from every other form here, and the difference is what makes a DNA report relevant to it. Its definitions section reads: "Congenital disorder Means an abnormality present at birth, whether apparent or not, that can cause illness or disease," and "Hereditary disorder Means an abnormality transmitted by gene(s) from parent to offspring, whether apparent or not, that can cause illness or disease." Exclusion K then removes the "Diagnosis or treatment of any hereditary disorder or any condition resulting from the hereditary disorder," and adds that "You may obtain a list of conditions we regard as breed-specific hereditary disorders through our Web site." Its pre-existing definition, "began or was contracted, manifested, or incurred before the effective date of this policy, whether or not the condition was discovered, diagnosed, or treated," has the same indifference to discovery.

Two things follow, both readings. First, a variant a dog has carried since conception fits "transmitted by gene(s)" and "present at birth" without anyone seeing anything, and VS-21 is the only one of the nine whose hereditary and congenital definitions apply "whether apparent or not." Second, exclusion K has no date in it. A hereditary disorder diagnosed at three years old is excluded at three years old, with or without a report at eight weeks. The report matters for what it adds to the argument that a later diagnosis is hereditary, and for which breed-specific list applies, and the list is not printed in the form.

The California form VS-G-3-CA (02-15) uses a thinner definition, "an abnormality that is genetically transmitted from parent to offspring and may cause illness or disease," word for word the NAIC model's Section 3C definition. Exclusion H removes "Diagnosis or treatment of any hereditary disorder or any condition caused by or resulting from a hereditary disorder, except as provided in section 7," and lists the conditions "on our website" or by telephone. Section 7 pays up to $275 for the diagnosis or medical treatment of a listed ineligible condition and up to $550 for its surgery, in neither case within the first twelve months. As printed, the two caps add to $825 (275 plus 550) in a policy term, before deductible and co-payment effects. The schedule's ineligible-conditions list runs on four-digit codes and names conditions by breed, such as 6403 Basset Hound Thrombopathia and 6024 Beagle Pain Syndrome, and by genetic mechanism, such as 6003 Inherited Cardiomyopathy.

That makes breed identification part of the hereditary clause for both Nationwide forms. The hereditary and bilateral exclusions guide covers how those definitions interact with paired-organ conditions.

How the nine forms treat genetic conditions

Before the pre-existing question is reached, the hereditary design of the policy has already sorted conditions into covered, excluded or add-on. A report matters in proportion to that design, so the table below puts the genetic wording of all nine side by side.

Quoted from each insurer's posted document. The add-on and endorsement terms for AKC and PetPartners are summarized only as far as the forms print them.

Counting the rows: four of the nine exclude hereditary conditions unless an add-on or a capped section applies (AKC, PetPartners, VS-21, VS-G-3-CA), three name hereditary conditions among covered illnesses (Figo, Spot, MetLife), and two have no genetic wording at all (Trupanion and Pets Best). A reader looking only at the DNA question can miss this entirely. Which of those three groups a policy belongs to can change the result of a cataract or a degenerative disorder diagnosed years later by more than a report does. The hereditary and bilateral exclusions guide reads the same split condition by condition.

Veterinary advice about a result

Three of the nine forms (MetLife, VS-G-3-CA and Pets Best) make veterinary advice a trigger on its own. MetLife adds "a diagnosis, care or Treatment" and defines Treatment to include "laboratory tests." A DNA report does not by itself satisfy any of those, but a report may not be left alone. A puppy with an at-risk result may be taken for an exam, and what the veterinarian writes about it is a different kind of record from the swab.

VS-G-3-CA and Pets Best attach advice to "any condition for which a veterinarian provided medical advice," and MetLife introduces its trio "with respect to a covered Pet's Illness or Injury." So the question is whether a note such as "carrier for the cataract variant, recheck eyes yearly" is medical advice for the condition that is later claimed. On the plain words it can be, and a form that counts advice has no slot for advice about risk. Spot reaches the same record by a different route, because an occurrence includes signs "recorded in your pet's medical record." Pets Best's "Present" test reaches signs "observable or reasonably known" whether or not they are charted, so there the chart matters less than what the owner or veterinarian could see. Figo's chronic-condition limb needs a condition "observed by You or Your Veterinary Provider," and AKC and PetPartners count a veterinarian's noticing of a departure from normal. In the advice-based forms and in Spot, a clinical note, as opposed to a laboratory report, is where the risk sits.

None of this is a reason to avoid or to seek veterinary follow-up, which belongs to the owner and the dog's veterinarian. It is a reason to know that the pet's chart is the document the forms operate on, and that a form applies its definition to a record written by someone else, in shorthand, for another purpose. The guide to insuring after a diagnosis shows how those chart lines are read once a condition is recorded. A cat's DNA result raises the same question with different breeds and genes, and the HCM guide handles it; the FIV guide works through how one laboratory result can land on four different dates under four wordings, which is the analysis to use if a result is repeated or retested.

Who pays for the swab

Whether a test is reimbursed is a separate question from whether its result counts, and the forms answer it through three gates: who orders and performs it, whether a sign prompted it, and whether the condition it addresses is excluded. Only Figo names the test. Its Part IV exclusion 22 removes "Costs for any Treatment for: a. Genetic/chromosome testing; b. Procedures to determine the suitability or categorization of Your Pet for breeding or genealogical purposes, including Penn HIP and OFA evaluations." On its words the exclusion does not depend on who orders the test or whether a sign prompted it, and it reaches OFA evaluations as well, the registry whose eye certification the cataract guide discusses.

The other eight reach the test, if at all, through the symptom gate or the preventive-care gate. AKC pays only for expenses "Medically Necessary to treat or diagnose a current covered Incident showing Symptoms," and adds that Treatment "must be performed by a licensed Veterinarian to be considered for eligibility"; PetPartners limits its benefit to "a current covered incident that is showing symptoms." Spot excludes "Preventive care without an occurrence (including but not limited to general health maintenance diagnostics, laboratory procedures ...)," and Treatment there means "Care that your veterinarian administers." MetLife defines Diagnostics as procedures "performed by a Veterinarian for the purpose of determining what disease or condition explains symptoms exhibited by Your Pet." Trupanion excludes "Preventive healthcare including routine screening" in 5.d(2). Pets Best excludes "Claims for Pets found to be healthy and presenting with no clinical symptoms," and VS-21 excludes "Preventive treatment or diagnostics associated with preventive treatment." VS-G-3-CA excludes "Routine, preventive, elective, or cosmetic diagnosis, treatment or procedures," and defines veterinary services as care "provided by a veterinarian who has physically examined your pet."

Four of those definitions (AKC, Spot, MetLife and VS-G-3-CA) already require a veterinarian to perform, administer or examine, so a swab mailed from home falls outside them before the preventive gate is reached. A test a veterinarian orders because a dog already has signs is the kind of expense the diagnostic benefits describe, but then a second gate applies. AKC and PetPartners exclude "Treatments or diagnostics of an Illness, Injury or service excluded by the Policy," Trupanion 5.e(13) excludes "Diagnostic tests for conditions excluded by this policy," Pets Best C.7 excludes "diagnostic tests ... related to Conditions not covered or restricted by this policy," and VS-21 exclusion T excludes "Diagnostic test(s) or treatment(s) for conditions excluded or limited by this policy." VS-G-3-CA opens its congenital and hereditary exclusions (G and H) with "Diagnosis or treatment of." So a veterinarian-ordered genetic test for a dog with signs of a condition the policy excludes is itself excluded in those six forms, and Figo's exclusion 22(a) reaches genetic testing in any case.

Readings of quoted wording for a swab ordered by an owner for a dog with no sign. OFA lists $65 per test for its University of Missouri tests (OFA page, November 3, 2026).

In every row but MetLife's the answer for an owner-ordered swab on a healthy dog is no, and MetLife's turns on a declarations page the sample does not itemize. That is not a defect in the policies; it is what preventive-care exclusions are written to do. The wellness plan guide covers the preventive-care riders that some insurers sell separately, and none of the nine documents lists a DNA or genetic test among a rider's items.

Records, applications and material facts

A result kept at home does not sit in any clinic's records, and the forms are built around clinic records. Trupanion's section 3.b says "You authorize us, at the time of enrollment, to contact any and all veterinary clinics or hospitals in your area to obtain all available medical records for your pet that exist prior to your enrollment," and that "Failure or refusal to disclose all medical history for your pet when requested may result in the denial of your claim(s) and the voiding of your policy. If your policy is voided, the policy premium paid will be refunded to you." Figo's Part II requires "twenty-four (24) months of medical or adoption records" with a first claim that is not for routine care only, and gives permission to gather medical information from all of the dog's veterinary providers. MetLife asks for "all Your Pet's medical and adoption records for the twelve-month period prior to the Date of Service (applicable only if this is Your first claim)." Pets Best authorizes contact with "any and all veterinary clinics or hospitals" at enrollment and any time after, and says that if an owner "cannot (or refuse) to disclose a complete medical history for your Pet when requested, we may deny your claim(s)." VS-G-3-CA requires "all medical and surgical records relating to any claim," and Spot has the owner authorize access to "all medical information and records that we need to assess your pet's health."

All nine also carry a clause about concealed or false information. Spot allows cancellation or rescission if the owner "misrepresented or concealed any material fact that would have affected our decision to provide coverage." Trupanion 4.d denies coverage where an insured "intentionally concealed or misrepresented any material fact or circumstance." Figo voids a policy for "intentional concealment, or misrepresentation of a material fact." AKC permits cancellation for a "material fact that We rely on to issue or administer coverage." MetLife permits cancellation where the policy "was obtained through fraud, misrepresentation or concealment in Your application." PetPartners lets the policy be voided for a concealed or misrepresented "material fact or circumstance." VS-21 and VS-G-3-CA say the insurer "will void your policy from its inception if we discover that you have misrepresented or omitted any material fact and we relied on your misrepresentation or omission in issuing this policy," and have the owner agree that "all the statements in your application and the declarations are true." Pets Best speaks of "false, misleading, and/or dishonest information." Seven of the nine use the words "material fact"; none of the nine defines material, none mentions a genetic result, and an application, which is where a question about one would appear, is not among the documents compared. PetPartners' insuring agreement says the agreement includes "your application," and its Washington endorsement removes that phrase.

The absence of a DNA question in these forms is therefore not an answer to whether the insurer's application asks one. What the application asks, and what the insurer treats as material, are questions for the insurer, to be put in writing with the reply kept. The forms give a reader no basis to withhold something an application does ask, and no basis to assume it will not. Nothing here is legal advice.

Ancestry panels are a separate record

A breed-ancestry result is a different document from a health panel, and the forms touch it in only a few places. Trupanion lists "Breed" among the enrollment factors that determine the premium. VS-21 ties its hereditary exclusion to "a list of conditions we regard as breed-specific hereditary disorders," and VS-G-3-CA's schedule names conditions by breed, as the codes above show. MetLife's sample policy is issued for "a 0 year old mixed dog." So a panel that moves a dog from "mixed" to a named breed can change which listed conditions a hereditary clause points at, and, at insurers that rate by breed, the premium class.

For a rescue dog the label on the intake paperwork is often a shelter's visual guess. The rescue dog guide covers what to ask when parentage is unknown, including what happens if a later DNA result differs from the label an insurer used. The new puppy guide covers the enrollment-timing side. The nine forms say nothing about re-rating after a breed result, so that question belongs to the declarations page and the insurer.

Two vendor statements beside the forms

Two test vendors have published statements about insurance. They are claims by sellers of the tests, not policy text, and both are general.

Wisdom Panel's blog (published March 8, 2024) says that "genetic test results are not typically part of the application process," that a pre-existing condition is one a pet "has either been diagnosed with by a veterinarian or is showing signs of before an insurance policy takes effect," and that "Any diagnosis that an insurance company would factor into a pet's eligibility would come from a veterinarian after performing an exam and any necessary testing, not from the results of a DNA test - even if that DNA test is done by a veterinarian and is part of a patient's medical record." It concludes that "pre-existing conditions can affect coverage and premiums, while genetic predispositions generally do not."

Embark's veterinary-resources page (dated September 13, 2022) says "pet health insurers we surveyed" told it that genetic screening will not prevent a dog from getting a policy, that "Genetic health screening is considered a prognostic test, not a diagnostic test," and that a clear, carrier or at-risk result "is not used to determine a pre-existing condition at this time." The page does not name the insurers surveyed.

Set beside the forms, the statements hold where a form counts only signs, observations, advice and treatment, which is five of the nine. They do not settle the other four. AKC and PetPartners count what "existed" without diagnosis; Trupanion counts "evidence" of potential manifestation and abnormalities "noted from ... screening," and defines diagnostic tests to include testing "before problems surface"; VS-21 counts what "began or was contracted" without discovery. Wisdom Panel's statement that a result in a veterinarian's record is still not a diagnosis runs into Pets Best's "whether or not the Condition is noted in your Pet's medical records" on one side and MetLife's definition of Treatment as including "laboratory tests" on the other. Embark's distinction between a "prognostic test" and a "diagnostic test" is a classification the vendor makes. Trupanion's definition of diagnostic tests does not use it.

Neither vendor page mentions hereditary exclusions, which is where the nine forms diverge most, or whether a policy reimburses the test. Both pages are also written from the viewpoint of enrollment: neither discusses a result that arrives while a policy is in force, a case taken up in the decision rows below. The two pages agree with each other; they are statements about insurers in general, and the forms show where an individual policy could differ.

Which wording to put to the insurer

Each situation names the clause that carries the weight and the question to put in writing; none says what to do for the dog.

Questions to settle before ordering a swab

• Does the application ask about genetic or DNA test results, and does the insurer treat a result with no sign as a pre-existing condition?
• Is a genotype an Illness that "existed," "evidence ... of their potential manifestation" or an "abnormality ... noted from ... screening" under this form, in the insurer's words?
• Does the policy exclude, cover or add on hereditary and congenital conditions, and is the list of breed-specific conditions in the form, on a website or on the declarations page?
• If a veterinarian writes a plan around a result, does that count as "medical advice" for the condition?
• Is the cost of a genetic test, ordered by an owner or a veterinarian, reimbursed under any rider or benefit?
• If an ancestry result changes the dog's breed, does the insurer re-rate the policy or change which listed conditions apply?

What a swab leaves unchanged

A DNA result changes what an owner knows about a dog and very little about what a policy owes. The waiting period, the annual limit, the reimbursement rate and the hereditary design come from the policy, not the lab, and the nine forms differ most on the last of those. The sensible order is to read the policy's hereditary and pre-existing wording first, using the policy reading guide, and to treat a report as a record to be dated and understood, not as a sorting event. The claims denial guide lists the other clauses that decide claims after a diagnosis.

This site ranks no insurer and publishes no quote. Get a live quote before deciding, and keep the insurer's answers to the questions above in writing.